Mapping of genetic deletions on the long arm of chromosome 4 in human esophageal adenocarcinomas.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 1866588)

Published in Am J Pathol on May 01, 1999

Authors

C A Rumpel1, S M Powell, C A Moskaluk

Author Affiliations

1: Departments of Pathology, Biochemistry and Molecular Genetics, and Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA.

Articles citing this

Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57

Molecular biology of Barrett's adenocarcinoma. Ann Surg (2001) 1.17

Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol (2001) 0.95

Novel DNA copy number losses in chromosome 12q12--q13 in adenoid cystic carcinoma. Neoplasia (2001) 0.90

A mortality gene(s) for the human adenocarcinoma line HeLa maps to a 130-kb region of human chromosome 4q22-q23. Neoplasia (2002) 0.82

Tumor suppress genes screening analysis on 4q in sporadic colorectal carcinoma. World J Gastroenterol (2008) 0.82

LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma. World J Gastroenterol (2010) 0.81

Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization. J Korean Med Sci (2006) 0.81

Multiple novel alternative splicing forms of FBXW7α have a translational modulatory function and show specific alteration in human cancer. PLoS One (2012) 0.79

Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence. World J Gastroenterol (2008) 0.76

Coculturing diverse clonal populations prevents the early-stage neoplastic progression that occurs in the separate clones. Proc Natl Acad Sci U S A (2000) 0.75

Novel APC gene mutations associated with protein alteration in diffuse type gastric cancer. BMC Med Genet (2017) 0.75

Articles cited by this

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38

A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00

Laser capture microdissection. Science (1996) 12.21

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (1996) 11.13

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17

Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13

Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet (1995) 3.76

Alterations of the PPP2R1B gene in human lung and colon cancer. Science (1998) 3.14

Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol (1994) 2.97

Mad-related genes in the human. Nat Genet (1996) 2.51

Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol (1997) 2.08

Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol (1988) 2.03

Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res (1997) 2.03

Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res (1996) 1.75

p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res (1997) 1.67

Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res (1992) 1.65

Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci U S A (1996) 1.53

Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol (1998) 1.36

Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. Br J Cancer (1998) 1.18

Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res (1996) 1.17

Genomic alterations associated with malignancy in head and neck cancer. Head Neck (1998) 1.17

Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res (1998) 1.13

Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res (1995) 1.07

Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosomes Cancer (1998) 1.04

Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q. Br J Cancer (1998) 1.02

Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene (1997) 1.02

Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis. Cancer Res (1997) 0.96

The molecular basis for carcinogenesis in metaplastic columnar-lined esophagus. Gastroenterol Clin North Am (1997) 0.89

Allelic deletion in 11p15 is a common occurrence in esophageal and gastric adenocarcinoma. Cancer (1998) 0.87

Deletion mapping of chromosome 4q in hepatocellular carcinoma. Int J Cancer (1998) 0.86

Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan. Cancer Lett (1998) 0.85

Articles by these authors

Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (1996) 11.13

Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res (2001) 6.78

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res (2001) 6.73

The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res (1996) 3.60

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res (1997) 3.17

PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science (1993) 2.80

Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62

IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol (1999) 2.58

Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38

Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res (1998) 2.20

Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19

Activating c-kit gene mutations in human germ cell tumors. Am J Pathol (1999) 2.15

Allelotype of pancreatic adenocarcinoma. Cancer Res (1994) 2.11

Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res (1999) 2.09

Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest (2001) 1.96

Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut (1998) 1.85

A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br J Clin Pharmacol (1998) 1.82

Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res (1996) 1.75

Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. Gastroenterology (2001) 1.74

Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology (2001) 1.69

Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother (2001) 1.53

Detection of Helicobacter pylori DNA in fecal samples from infected individuals. J Clin Microbiol (1999) 1.48

Prevalence of Campylobacter species, Helicobacter pylori and Arcobacter species in stool samples from the Venda region, Limpopo, South Africa: studies using molecular diagnostic methods. J Infect (2006) 1.47

Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells. Oncogene (2006) 1.44

Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology (1994) 1.41

KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol (1999) 1.40

Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma. Hum Pathol (1999) 1.37

A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria. Am J Trop Med Hyg (1998) 1.35

Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. Br J Clin Pharmacol (2001) 1.32

Expression profiling of gastric adenocarcinoma using cDNA array. Int J Cancer (2001) 1.23

Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. Am J Pathol (1997) 1.15

TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene (2012) 1.14

Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res (1998) 1.13

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity. Oncogene (2006) 1.11

Origin of microsatellite instability in gastric cancer. Am J Pathol (1999) 1.10

Physiological covalent regulation of rat liver branched-chain alpha-ketoacid dehydrogenase. Arch Biochem Biophys (1985) 1.10

The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology (1997) 1.10

Establishing a tumour bank: banking, informatics and ethics. Br J Cancer (2004) 1.09

Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors. Cancer Res (1997) 1.09

Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes. Br J Pharmacol (1998) 1.09

Allelotype of gastric adenocarcinoma. Cancer Res (1999) 1.08

Regulation of branched-chain alpha-ketoacid dehydrogenase complex by covalent modification. Adv Enzyme Regul (1986) 1.03

Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res (2001) 1.03

Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol (2001) 0.96

Regulation of the branched-chain 2-oxo acid dehydrogenase complex in hepatocytes isolated from rats fed on a low-protein diet. Biochem J (1986) 0.94

Hereditary desmoid disease in a family with a germline Alu I repeat mutation of the APC gene. Hum Hered (1999) 0.92

Glucose tolerance in lichen planus. Br J Dermatol (1974) 0.91

Novel DNA copy number losses in chromosome 12q12--q13 in adenoid cystic carcinoma. Neoplasia (2001) 0.90

Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum Pathol (1999) 0.89

Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification. Oncogene (2009) 0.88

Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas. Hum Mutat (1997) 0.87

Impact of primary tumour stage on survival in dogs with solitary lung tumours. J Small Anim Pract (2007) 0.86

Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venereol (2000) 0.85

Construct validity in a high-fidelity prostate exam simulator. Prostate Cancer Prostatic Dis (2011) 0.85

Evidence for functional ATP-sensitive (K(ATP)) potassium channels in human and equine articular chondrocytes. Osteoarthritis Cartilage (2006) 0.84

Overexpression of CEBPbeta correlates with decreased TFF1 in gastric cancer. Oncogene (2006) 0.83

An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12. Cancer Res (1995) 0.82

Surgical management of pulmonary infections in chronic granulomatous disease of childhood. Ann Thorac Surg (1993) 0.82

Allergic contact dermatitis from Granuflex hydrocolloid dressing. Contact Dermatitis (1994) 0.81

Sex-specific fetal lung development and müllerian inhibiting substance. Am Rev Respir Dis (1990) 0.81

The effects of frozen tissue storage conditions on the integrity of RNA and protein. Biotech Histochem (2014) 0.80

Nutritional and hormonal regulation of the activity state of hepatic branched-chain alpha-keto acid dehydrogenase complex. Ann N Y Acad Sci (1989) 0.80

EGF and PGE2: effects on corneal endothelial cell migration and monolayer spreading during wound repair in vitro. Curr Eye Res (1995) 0.80

Evaluation of a permeable reactive barrier to capture and degrade hydrocarbon contaminants. Environ Sci Pollut Res Int (2015) 0.79

Thoracotomy for pulmonary mycoses in non-HIV-immunosuppressed patients. Ann Thorac Surg (1994) 0.78

Contact sensitivity in community-based leg ulcer patients. Clin Exp Dermatol (1988) 0.77

Mullerian inhibiting substance fractionation by dye affinity chromatography. Cell (1983) 0.77

High incidence of contact dermatitis in leg-ulcer patients--implications for management. Clin Exp Dermatol (1991) 0.77

Isolation of YAC insert sequences by representational difference analysis. Nucleic Acids Res (1995) 0.75

Sorbitan sesquioleate--a potential allergen in leg ulcer patients. Contact Dermatitis (1994) 0.75

Cutaneous reactivity of the hands in nickel-sensitive patients with hand eczema. Contact Dermatitis (1998) 0.75

An unusual case of allergic contact dermatitis in a veterinary surgeon. Contact Dermatitis (1990) 0.75

Glucose-6-phosphate dehydrogenase in lichen planus skin. Br J Dermatol (1976) 0.75

The rate of removal and the compositional changes of diesel in Antarctic marine sediment. Sci Total Environ (2011) 0.75

Contact dermatitis in a bagpipes maker. Contact Dermatitis (2003) 0.75

Use of near infrared spectroscopy to predict microbial numbers on Atlantic salmon. Food Microbiol (2012) 0.75

An outbreak of contact dermatitis from Rhus verniciflua (Toxicodendron vernicifluum). Contact Dermatitis (1986) 0.75

Scar excision in revision neck surgery. Clin Otolaryngol (2007) 0.75

Cicatricial pemphigoid with nail dystrophy. Clin Exp Dermatol (1985) 0.75

The problems of rubber hypersensitivity (Types I and IV) in chronic leg ulcer and stasis eczema patients. Contact Dermatitis (1999) 0.75

Genetic syndromes and genetic tests in colorectal cancer. Semin Gastrointest Dis (2000) 0.75

BCG. N Engl J Med (1970) 0.75

Xenografting human colon cancers. Methods Mol Med (2001) 0.75

Sailing past the horizon. The histologic diagnosis of celiac disease in "nonflat" intestinal mucosa. Am J Clin Pathol (2001) 0.75

Smallpox vaccination. Clin Pediatr (Phila) (1972) 0.75

Contact urticaria to phosphorus sesquisulphide. Contact Dermatitis (1983) 0.75

Contact sensitivity to the stearyl alcohol in Efudix cream (5-fluorouracil). Contact Dermatitis (1992) 0.75

The cutaneous reactions to kallikrein, prostaglandin and thurfyl nicotinate in chronic urticaria and the effect of polyphloretin phosphate. Acta Derm Venereol (1976) 0.75

Allergic contact dermatitis from BHT in leg ulcer patients. Contact Dermatitis (1989) 0.75

Hioxyl sensitivity. Contact Dermatitis (1990) 0.75